Alyeska Investment Group
NMRD

Alyeska Investment Group’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Alyeska Investment Group’s Portfolio NMRD Stock Details NMRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-845,060
Closed -$185K – 663
2023
Q4 		$185K Sell
845,060
-997,505
-54% -$239K ﹤0.01% 479
2023
Q3 		$580K Sell
1,842,565
-640,706
-26% -$444K ﹤0.01% 441
2023
Q2 		$2.3M Hold
2,483,271
– – 0.02% 402
2023
Q1 		$2.22M Buy
+2,483,271
New +$3.21M 0.02% 347

Other funds holding NMRD

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Alyeska Investment Group's NMRD Position: Q1 2024 in Review

Alyeska Investment Group sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q1 2024, closing a stake of 845,060 shares — an estimated $185K sold.

Alyeska Investment Group first reported a position in NMRD in Q1 2023 and held it in 4 quarters. The position peaked at $2.3M in Q2 2023. 2 funds tracked by Wall St. Rank hold NMRD as of Q1 2024.

  • Alyeska Investment Group reported no remaining Nemaura Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Alyeska Investment Group sold 845,060 Nemaura Medical, Inc. Common Stock shares in Q1 2024, an estimated $185K.
  • Alyeska Investment Group first reported a position in Nemaura Medical, Inc. Common Stock in Q1 2023 and held it in 4 quarters.
  • Alyeska Investment Group's Nemaura Medical, Inc. Common Stock position peaked at $2.3M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q1 2024.

Based on Alyeska Investment Group's 13F filing for Q1 2024, filed 15 May 2024.